Back

Metabolic Acidosis in Chronic Kidney Disease

Also known as: Metabolic Acidosis of Chronic Kidney Disease

Metabolic acidosis in chronic kidney disease is a serum bicarbonate under 22 mmol/L due to reduced renal net acid excretion. Prevalence rises from 5% at stage G3a to more than 30% at G4 to G5. The daily endogenous and dietary acid load is about 1 mmol/kg; the failing kidney cannot generate enough ammonia and excrete titratable acid, so buffers (bone, muscle) are consumed. Early disease produces a normal anion gap (hyperchloraemic) acidosis; advanced disease adds a raised anion gap from retained phosphate, sulphate and organic anions.

Consequences. Faster decline in eGFR, bone demineralisation and fracture, muscle protein catabolism and sarcopenia, insulin resistance, hyperkalaemia, impaired growth in children, worse cardiovascular outcomes, and higher mortality.

Related

Clinical toolsCalculators

Latest content

Atlas’ Videos

On the evidence

Doses are traceable.

Management sections cite the guideline they came from. Atlas supports clinical judgement rather than replacing it; verify against current national guidance and the patient in front of you.

Learn it.
Know it.
Own it.